Cagrilintide · Research brief

Cagrilintide Research Peptide: Storage, Studies & COAs

Real Peptides Research TeamEditorial

Updated September 30, 202610 min read

52 WORDS

Short answer

The fastest way to ruin a cagrilintide research peptide vial isn't heat. It's condensation. Open a frozen vial before it has warmed to room temperature and ambient moisture settles straight onto the lyophilised cake, where it starts hydrolysing the peptide backbone. Nothing about the cake's appearance afterwards will tell you it happened.

Key takeaways

Lyophilised cagrilintide research peptide should be held at −20°C or colder, sealed and desiccated, with −80°C preferred for long-term storage.
Reconstituted solution belongs at 2–8°C and is commonly documented as usable for up to 28 days when bacteriostatic water containing roughly 0.9% benzyl alcohol is the diluent.
Cagrilintide is an acylated amylin analogue acting at AMY1, AMY2 and AMY3 receptors formed by the calcitonin receptor paired with RAMP1, RAMP2 or RAMP3.
Frost-free domestic freezers run scheduled defrost cycles that create repeated thermal excursions, making manual-defrost or laboratory freezers the correct choice.
Net peptide content on the certificate, not gross vial weight, is the figure every mg-per-mL calculation must use.
Cagrilintide is not an approved drug product and is supplied for in vitro and preclinical laboratory research only.

We supply research-grade peptides to laboratories, and handling questions dominate our inbox. The storage rules are short. The failure modes aren't.

How should researchers store cagrilintide research peptide?

Store lyophilised cagrilintide research peptide at −20°C or colder, sealed, desiccated and protected from light. After reconstitution with bacteriostatic water, hold the solution at 2–8°C and treat it as short-lived, commonly documented as up to 28 days. Minimise freeze-thaw cycles, because each one accelerates aggregation in acylated peptides.

One oversimplification is worth correcting immediately: 'just refrigerate it' does not cover this compound. Refrigeration applies to reconstituted solution, freezing applies to dry powder, and the two are not interchangeable. Below we cover what published cagrilintide clinical studies report, how to handle a cagrilintide research vial without silently degrading it, how to read a certificate of analysis, and what realistic supplier shipping looks like.

What the published cagrilintide literature actually reports

Cagrilintide is a long-acting, acylated analogue of amylin, the hormone co-secreted with insulin by pancreatic beta cells. It acts as a dual amylin and calcitonin receptor agonist, shortened in the literature to DACRA. Amylin receptors aren't standalone proteins: they form when the calcitonin receptor pairs with receptor activity-modifying proteins (RAMP1, RAMP2 or RAMP3) to create the AMY1, AMY2 and AMY3 subtypes. Signalling at those receptors in the area postrema is associated in the research with slowed gastric emptying, suppressed postprandial glucagon, and increased satiety signalling.

Why does acylation matter to anyone holding a vial? The fatty-acid side chain drives albumin binding, which extended the molecule's duration enough for once-weekly administration in trials. Pramlintide, the earlier amylin analogue to reach the clinic, needed multiple daily injections.

Phase 2 dose-finding work on once-weekly cagrilintide in overweight and obesity was published in The Lancet in 2021 and reported dose-dependent body weight reductions versus placebo (PubMed). The cagrilintide + semaglutide research peptide pairing was first characterised in a phase 1b study of concomitant administration, also published in The Lancet in 2021 (PubMed). Later fixed-dose combination programmes have been reported by the sponsor, and researchers should read those primary publications directly rather than trusting vendor summaries of cagrilintide study results.

Cagrilintide is not an approved drug product. Material supplied for cagrilintide laboratory research is for in vitro and preclinical use only, never for human or veterinary consumption. Anyone with a question about an animal's health should speak with their veterinarian rather than sourcing research compounds.

Cold chain, freeze-thaw and the errors that quietly ruin a vial

Degradation of a cagrilintide research peptide vial is almost always cumulative rather than catastrophic. Lyophilised material belongs at −20°C or colder, sealed with its desiccant, in the dark. For long-term holding, −80°C is preferable.

Here's the mistake most handling guides skip entirely: the freezer type matters more than the setpoint. A domestic frost-free freezer runs an automatic defrost cycle that warms its interior on a schedule, so a vial nominally stored at −20°C may be experiencing dozens of small thermal excursions a month. A manual-defrost or laboratory-grade freezer holds a genuinely flat temperature. That's the difference between a stable lyophilisate and one that has slowly absorbed moisture from cycling humidity.

The second error is procedural. Let a sealed vial equilibrate to room temperature for 15 to 20 minutes before breaking the seal, because a cold stopper pulls condensation out of room air the instant it's exposed. After reconstitution, don't treat one stopper as a repeat-access port. Every puncture sheds elastomer particulate and admits air, and peptide in dilute solution adsorbs to borosilicate glass, so a shared stock vial loses measurable concentration over time. Single-use aliquots in low-binding tubes solve both problems at once.

Swirl, never vortex. Shear from vortexing promotes aggregation in acylated peptides. And know your diluent: bacteriostatic water contains roughly 0.9% benzyl alcohol as a preservative, while sterile water contains none and offers no protection against microbial growth in a multi-day working solution.

What a certificate of analysis should tell you before the vial ships

A usable certificate of analysis for cagrilintide scientific research carries four things: an RP-HPLC chromatogram with a stated purity percentage, mass spectrometry confirming the observed molecular weight against the expected sequence, a lot number that matches the physical vial label, and the date of analysis. A generic PDF with no lot number is marketing, not documentation.

The detail that trips up new labs is net peptide content. Gross vial weight includes counter-ions from synthesis, typically trifluoroacetate or acetate salt, plus residual water. A vial labelled at a given gross milligram weight contains less actual peptide than the label implies unless net content is stated separately on the certificate. Take a purely hypothetical worked example: if a certificate reports 80% net peptide content for a nominal 20 mg vial, the arithmetic gives 16 mg of peptide, and every mg-per-mL calculation downstream must use 16, not 20.

The arithmetic itself is trivial once net content is known. Dividing net peptide mass by the reconstitution volume gives concentration: 16 mg into 2 mL of diluent yields 8 mg/mL. Record that number on the vial alongside the reconstitution date. We've reviewed a lot of laboratory handling logs, and undated vials are the single most common documentation gap we see.

Judging a supplier on more than shipping speed

Fast dispatch is a logistics achievement, not a quality signal, and the two get conflated constantly in this market. Lyophilised peptide is the forgiving format precisely because dry powder tolerates short ambient transit, which is why serious suppliers ship it dry in insulated packaging with gel packs rather than shipping pre-mixed solution.

What actually separates suppliers is traceability. Small-batch synthesis with per-lot analytical testing means the certificate you receive describes the vial in your hand, not an earlier production run of the same sequence. Ask three questions before ordering cagrilintide for research: is the COA lot-specific, was purity determined by HPLC with a mass spec confirmation, and what happens operationally if a shipment is delayed in transit over a weekend. A supplier who answers all three without hedging is telling you their quality system exists. One who redirects to delivery times is telling you something too.

We won't characterise any competitor's internal logistics, because nobody outside a company can verify them honestly. What any researcher can verify is documentation, and that's the part worth weighting.

Cagrilintide Research Peptide: Storage Format Comparison

The same compound has four practical storage states, and each has a different failure mode. This table maps what to expect from each, so a cagrilintide research vial gets handled according to its current form rather than a single blanket rule.

Vial State	Recommended Temperature	Practical Working Window	Primary Degradation Risk	Bottom Line
Sealed lyophilised powder	−20°C or colder, dark, desiccated	The longest stable window of any format, measured in months rather than weeks	Moisture ingress and repeated defrost cycling in frost-free freezers	This is the correct default state; keep it dry, dark and genuinely frozen
Lyophilised powder in transit	Ambient inside insulated packaging with gel packs	Short transit of one to a few days is generally tolerated	Sustained heat above roughly 25°C across repeated days in a hot vehicle or mailbox	Dry powder is the forgiving format, which is why reputable suppliers ship it this way
Reconstituted solution, refrigerated	2–8°C, upright, protected from light	Commonly documented as up to 28 days when bacteriostatic water is used	Microbial growth, aggregation, and adsorption of peptide onto glass surfaces	Write the reconstitution date on the vial immediately; an undated solution is unusable data
Reconstituted solution, frozen	−20°C in single-use aliquots only	Extends usable life, but only if each aliquot is thawed exactly once	Freeze-thaw aggregation and irreversible loss of active material	Acceptable with single-use aliquots, never with a shared multi-draw stock vial

What If: Cagrilintide Handling Scenarios

What if a shipment arrives with the ice packs completely thawed?

Assess the format first: thawed gel packs around sealed lyophilised powder are usually a non-event, while thawed packs around any pre-mixed solution are not. Dry powder tolerates short ambient transit because there is no aqueous phase for hydrolysis or microbial growth. Document the arrival condition, photograph the packaging, refrigerate or freeze immediately, and contact the supplier so the lot is flagged. If transit stretched across several days of genuine heat, ask whether replacement material is available rather than starting an assay on an unknown.

What if the lyophilised cake looks cracked, shrunken or stuck to the vial wall?

Don't discard it automatically, but do record it. Cake appearance is affected by lyophilisation cycle parameters, fill volume and vacuum quality, and a collapsed or wall-adhered cake can still meet purity specification. What appearance cannot tell you is whether the peptide has hydrolysed. If the cake looks visibly wet, gummy or discoloured rather than simply cracked, that suggests moisture exposure and the vial should be set aside. The certificate of analysis, not the cake, is the evidence of identity and purity.

What if a reconstituted vial was left at room temperature overnight?

Treat that vial as compromised for quantitative work. Room-temperature solution accelerates both aggregation and microbial risk, and benzyl alcohol in bacteriostatic water is bacteriostatic rather than sterilising, so it slows growth without preventing it indefinitely. There is no home test that distinguishes an intact acylated peptide from a partially aggregated one, and turbidity appears only after substantial damage. For exploratory work the excursion may be tolerable, but any result generated from that vial should carry a handling annotation.

What if the lot number on the COA doesn't match the vial label?

Stop and query it before opening anything. A certificate is only meaningful when it describes the specific synthesis batch in front of you, and a mismatch means the analytical data you hold belongs to different material. Legitimate suppliers resolve this in minutes by reissuing the correct lot document. If a supplier tells you the numbers are interchangeable or that all batches are identical, that answer is the problem, not the paperwork.

The unglamorous truth about peptide supplier claims

Let's be direct about this: purity percentages printed on a website mean nothing without a lot-specific chromatogram attached to them. Anyone can type 99%. A supplier that publishes the actual HPLC trace and the mass spec result for the batch you received is making a falsifiable claim, and a falsifiable claim is the only kind worth anything in laboratory procurement. The same logic applies to shipping speed. Overnight delivery of undocumented material is fast delivery of an unknown, and an unknown compound generates unknown data no matter how quickly it arrived.

Further reading across our own documentation covers the cagrilintide product page, our certificates of analysis for lot-specific HPLC and mass spectrometry data, the wider research peptide catalog, and our location and contact details for questions about sourcing and handling.

A cagrilintide research peptide vial is among the least forgiving things in a laboratory fridge, and not because the molecule is exotic. It's because every degradation pathway that matters is invisible. Assay variance gets blamed on the compound far more often than it gets blamed on the freezer that defrosts itself at 3am, or the stock vial punctured fourteen times, or the calculation that used gross weight instead of net peptide content. The chemistry is rarely the weak link. The handling log almost always is, and a handling log costs nothing except the discipline to write the date on the vial.

References

Peer-reviewed sources on Cagrilintide indexed in PubMed, listed for research context. Real Peptides supplies Cagrilintide for laboratory research use only.

CagriSema Versus Semaglutide Monotherapy or Placebo for Obesity: A Systematic Review and Meta-Analysis of Randomized Controlled Trials with GRADE Assessment. The American journal of cardiology, 2026. PMID 41759565. doi:10.1016/j.amjcard.2026.02.030
Efficacy and Safety of Cagrilintide Alone and in Combination with Semaglutide (Cagrisema) as Anti-Obesity Medications: A Systematic Review and Meta-Analysis. Indian journal of endocrinology and metabolism, 2024. PMID 39676787. doi:10.4103/ijem.ijem_45_24
Efficacy and safety of co-administered cagrilintide and semaglutide versus semaglutide alone in adults with overweight or obesity with or without type 2 diabetes in Japan and Taiwan (REDEFINE 5): a multicentre, randomised, active-controlled, phase 3a trial. The lancet. Diabetes & endocrinology, 2026. PMID 42009015. doi:10.1016/S2213-8587(25)00402-4
Coadministered Cagrilintide and Semaglutide in Adults with Overweight or Obesity. The New England journal of medicine, 2025. PMID 40544433. doi:10.1056/NEJMoa2502081
Cagrilintide-Semaglutide in Adults with Overweight or Obesity and Type 2 Diabetes. The New England journal of medicine, 2025. PMID 40544432. doi:10.1056/NEJMoa2502082
Cagrilintide lowers bodyweight through brain amylin receptors 1 and 3. EBioMedicine, 2025. PMID 40609154. doi:10.1016/j.ebiom.2025.105836
Structural and dynamic features of cagrilintide binding to calcitonin and amylin receptors. Nature communications, 2025. PMID 40204768. doi:10.1038/s41467-025-58680-y
In adults with overweight or obesity, weekly subcutaneous cagrilintide-semaglutide increased weight loss at 68 wk. Annals of internal medicine, 2025. PMID 41052437. doi:10.7326/ANNALS-25-03745-JC

Build a pack

Researching more than one compound?

Build a multi-vial pack and the discount applies automatically as you add doses.

Start a pack

Questions

Storage requirements don't change by supplier. Any lyophilised cagrilintide should be held at −20°C or colder, sealed, desiccated and protected from light, with −80°C preferred for long-term holding. Once reconstituted, keep the solution at 2–8°C and minimise freeze-thaw cycles. Always follow the specific lot documentation supplied with your vial.

We can't speak to another company's internal logistics, and nobody outside a business can verify those claims honestly. What makes fast dispatch possible generally is in-stock lyophilised inventory, since dry powder ships in insulated packaging with gel packs and tolerates short ambient transit. Speed itself is not a quality indicator; lot-specific documentation is.

Cagrilintide is studied as a long-acting acylated amylin analogue and dual amylin and calcitonin receptor agonist. Published research has examined its effects on body weight, gastric emptying and glucagon signalling, including phase 2 dose-finding work published in The Lancet in 2021. It is supplied strictly for in vitro and preclinical laboratory research.

No. Cagrilintide research peptide supplied by research chemical vendors is not an approved drug product and is designated for laboratory research use only, never for human or veterinary consumption. Anyone with a health question concerning an animal should consult their veterinarian rather than sourcing research compounds.

Pricing varies widely by supplier, vial size, purity specification and whether lot-specific analytical testing is included. The more useful comparison is cost per verified milligram of net peptide content rather than the sticker price on a gross-weight vial, because untested material at a lower price often costs more in wasted assay time.

They act on entirely different receptor systems. Semaglutide is a GLP-1 receptor agonist, while cagrilintide is an amylin analogue acting at calcitonin receptor and RAMP complexes known as AMY1, AMY2 and AMY3. Research interest in combining them stems from the fact that the two pathways are complementary rather than overlapping.

Combination research examines whether concurrent amylin and GLP-1 receptor agonism produces effects beyond either mechanism alone. The pairing was first characterised in a phase 1b study of concomitant administration published in The Lancet in 2021, with later fixed-dose combination programmes reported subsequently. Researchers should consult the primary publications rather than vendor summaries.

As few as possible, and ideally once. Each freeze-thaw cycle promotes aggregation in acylated peptides, and the damage is cumulative and invisible until turbidity appears at an advanced stage. The standard laboratory solution is dividing reconstituted material into single-use aliquots in low-binding tubes so each aliquot thaws exactly one time.

Four elements: an RP-HPLC chromatogram with a stated purity percentage, mass spectrometry confirming observed molecular weight against the expected sequence, a lot number matching the physical vial label, and the analysis date. Net peptide content should also be stated separately, since gross vial weight includes counter-ion salt and residual water.

Cagrilintide is not an approved drug product. It has been evaluated in clinical trials, including published phase 1b and phase 2 studies, but material sold by research suppliers is designated research use only and is not manufactured, labelled or intended as a medicine.

The 28-day window is a standard laboratory convention tied to bacteriostatic water, which contains roughly 0.9% benzyl alcohol as a preservative. Benzyl alcohol slows microbial growth rather than preventing it indefinitely, and aggregation plus adsorption to glass gradually reduce effective concentration in solution regardless of microbial status.

RESEARCH USE ONLY · NOT EVALUATED BY THE FDA